Researchers at CIMA have identified a biomarker which offers prognosis after lung cancer surgery

by CIMA - Centro de Investigación Médica Aplicada

The research work led by CIMA has identified a molecule, called TMPRSS4, which acts as a biomarker for the prognosis of lung cancer. "By means of complex technological systems called "microarrays" and...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Ona Therapeutics Raises $86.6 Million Se...

by Ysios Capital

Proceeds to support clinical development of lead first-in-class progra...

Photos Stream